In the BioHarmony Drug Report Database

"Preview" Icon

Fosphenytoin

Cerebyx, Sesquient (fosphenytoin) is a small molecule pharmaceutical. Fosphenytoin was first approved as Cerebyx on 1996-08-05. It is used to treat epilepsy, seizures, and status epilepticus in the USA. Fosphenytoin sodium’s patent is valid until 2033-02-27 (FDA).

 

Trade Name

 

Cerebyx, Sesquient
 

Common Name

 

fosphenytoin
 

ChEMBL ID

 

CHEMBL1201336
 

Indication

 

epilepsy, seizures, status epilepticus
 

Drug Class

 

Antiepileptics (hydantoin derivatives); phosphoro-derivatives

Image (chem structure or protein)

Fosphenytoin structure rendering